Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study

Antiplatelet therapy with clopidogrel has been shown to reduce major adverse cardiac events in acute coronary syndromes and after percutaneous interventions. This effect is not only due to its anti-platelet effect but also possibly due to an anti-inflammatory effect. The effect of clopidogrel cessat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wykrzykowska, Joanna J., Warnholtz, Ascan, de Jaeger, Peter, Curzen, Nick, Oldroyd, Keith G., Collet, Jean Philippe, Ten Berg, Jurrien M., Rademaker, Tessa, Goedhart, Dick, Lissens, Jurgen, Kint, Peter-Paul, Serruys, Patrick W.
Formato: Texto
Lenguaje:English
Publicado: Springer US 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766044/
https://www.ncbi.nlm.nih.gov/pubmed/19504052
http://dx.doi.org/10.1007/s11239-009-0354-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766044/
https://www.ncbi.nlm.nih.gov/pubmed/19504052
http://dx.doi.org/10.1007/s11239-009-0354-y

Ejemplares similares